Evaluation of anticancer medicinal products in man - addendum on paediatric oncology

Current effective version

PDF iconAdopted guideline

Reference numberCPMP/EWP/569/02
Effective from01/01/2004
KeywordsChildhood cancer, childhood malignancy, predictive model systems, xenograft models
DescriptionThis document is an addendum to the guideline on evaluation of anticancer medicinal products in man. It aims to complement the current guideline with specific regulatory requirements related to paediatric oncology. It provides more specific information on the design and conduct of phase I trials in padiatric patients.

Related content

How useful was this page?

Add your rating